Targeting of the proteasome worsens atherosclerosis?
Ludwig
Antje
A
Meiners
Silke
S
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001897:Boronic Acids / Q000494:pharmacology*; D001920:Bradykinin / Q000494:pharmacology; D002791:Cholesterol, Dietary / Q000494:pharmacology; D003324:Coronary Artery Disease / Q000201:enzymology* / Q000473:pathology; D003326:Coronary Circulation / Q000187:drug effects; D004151:Dipeptides / Q000494:pharmacology*; D004789:Enzyme Activation / Q000187:drug effects; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006937:Hypercholesterolemia / Q000201:enzymology; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D009599:Nitroprusside / Q000494:pharmacology; D018384:Oxidative Stress / Q000187:drug effects; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism*; D061988:Proteasome Inhibitors; D013552:Swine; D025801:Ubiquitin / Q000378:metabolism; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology
D001897:Boronic Acids; D002791:Cholesterol, Dietary; D004151:Dipeptides; C509910:N-(4-morpholine)carbonyl-beta-(1-naphthyl)-alanyl-leucine boronic acid; D061988:Proteasome Inhibitors; D025801:Ubiquitin; D014665:Vasodilator Agents; D009599:Nitroprusside; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D046988:Proteasome Endopeptidase Complex; D001920:Bradykinin